Ken is our President and Chief Executive Officer and a member of our board of directors. He has more than 10 years’ experience developing and building companies in the life sciences and the diagnostic industry. Prior to joining Metacrine, he was the Chief Executive Officer of Ariosa Diagnostics, Inc., a DNA molecular diagnostics company. Before that he was a Vice President at Venrock, a venture capital firm, leading investments in private and public healthcare companies. Previously, Ken trained as both an internist and gastroenterologist and conducted translational and clinical outcome research at the University of California, San Francisco, University of Washington and the Fred Hutchinson Cancer Center. He started his business career as a consultant at McKinsey. Ken also serves as Executive Chairman of Omniome, a DNA sequencing company. He holds a B.S. in biology from the Massachusetts Institute of Technology and an M.D. from the University of California, San Francisco.